HomeStock ScreenerEIKO Lifesciences

EIKO Lifesciences Current Share Price | EIKO Lifesciences Stock Screener

EIKO Specialty Chemicals
Live Share Price BSE
₹44.16
▲ 0.29 (0.66%)
2026-09-18 00:00:00
As of September 18, 2026, the live EIKO Lifesciences share price (BSE: EIKO) is ₹44.16, up 0.66% from the previous close, with shares trading between ₹43.98 and ₹44.60 in today's trading session, and a 52-week range of ₹43.87–₹62.03. Browse EIKO financial statements to support your investment research. Use the EIKO Lifesciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
EIKO Lifesciences Market Cap ₹65.45 Cr.
EIKO P/E Ratio (TTM) 11.70
EIKO Lifesciences P/B Ratio 1.01
EPS (TTM) ₹3.26
Dividend Yield -
Debt to Equity 0.06
EIKO 52 Week High ₹62.03
EIKO Lifesciences 52 Week Low ₹43.87
Operating Margin 12.00%
Profit Margin 11.76%
EIKO Revenue (TTM) ₹17.00
EBITDA ₹2.00
Net Income ₹2.00
Total Assets ₹89.00
Total Equity ₹70.00

EIKO Lifesciences Current Share Price Chart

Track the current EIKO Lifesciences share price and stock price with an interactive chart. Analyse EIKO price trends, trading volume, historical performance, and volatility across different timeframes — the complete EIKO Lifesciences stock quote in one place.

EIKO Lifesciences Company Profile - Fundamental Screener

Screen EIKO Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for EIKO shares.
Sector Chemicals
Industry Specialty Chemicals
Sub-Sector Specialty Chemicals
Segment E
ISIN INE666Q01016

EIKO Lifesciences Balance Sheet Screener

Screen EIKO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2026 2025 2020 2019 2018
Assets
Total Assets 89 66 12 9 11
Current Assets 47 33 5 4 6
Fixed Assets 22 23 2 2 2
Liabilities
Total Liabilities 0 0 0 0 0
Current Liabilities 4 3 2 0 1
Non-Current Liabilities 0 0 0 0 0
Shareholders' Equity
Total Equity 70 57 1 5 6
Share Capital 14 14 4 4 4
Reserves & Surplus 50 43 -1 1 2

EIKO Lifesciences Income Statement Screener - Profit & Revenue Analysis

Screen EIKO Lifesciences income statement and profit fundamentals. Analyze EIKO quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for EIKO Lifesciences share price evaluation.
Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2020-Sept 2020-Jun 2020-Mar 2019-Dec 2019-Sept 2019-Jun
Revenue 17 19 12 12 11 12 8 8 11 1 1 1 3 4 2
Expenses 15 16 10 10 9 10 7 8 10 1 0 2 5 6 3
EBITDA 2 2 2 2 2 2 1 1 1 0 0 -1 -1 -2 0
Operating Profit % 12.00% 12.00% 16.00% 15.00% 14.00% 12.00% 9.00% 5.00% 4.00% -6.00% 25.00% -148.00% -42.00% -44.00% -18.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 2 2 2 2 2 2 1 0 1 0 0 -1 -2 -2 -1
Tax 1 1 1 0 0 0 0 0 0 0 0 0 0 -1 0
Net Profit 2 2 1 1 1 1 0 0 0 0 0 -1 -1 -1 0
EPS 0.91 0.93 0.88 0.78 0.66 0.80 0.32 0.22 0.29 -0.14 0.17 -1.08 -1.55 -1.87 -0.50

EIKO Lifesciences Cash Flow Screener - Liquidity Fundamentals

Screen EIKO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2026-March 2025-March 2020-March 2019-March 2018-March 2017-March
Operating Activities 2 3 0 0 0 0
Investing Activities -9 -11 -1 0 0 0
Financing Activities 8 7 1 -1 0 0
Net Cash Flow 2 -2 0 -1 0 0

EIKO Lifesciences Shareholding Pattern Screener

See EIKO Lifesciences shareholding pattern with promoter, FII, and DII holdings. Check EIKO Lifesciences promoter holding and ownership changes for EIKO on TickJournal.
Item 2026-Jun 2026-Mar 2026-Feb 2025-Dec 2025-Sept 2025-Aug 2025-Jun 2025-Mar
Promoter Holding 39.91% 39.91% 39.91% 37.17% 37.17% 37.11% 36.74% 36.23%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 42.34% 41.69% 41.65% 43.38% 43.37% 43.49% 44.35% 44.38%
Other Holding 17.76% 18.41% 18.44% 19.46% 19.47% 19.40% 18.91% 19.39%
Shareholder Count 3,019 2,969 3,028 3,092 3,150 3,203 3,322 3,336

EIKO Lifesciences Share Dividend Screener - Share Yield Analysis

Check EIKO Lifesciences dividend history with payout and yield data. View EIKO Lifesciences dividend details including ex-dates and amounts for EIKO stock.
No dividends declared by EIKO Lifesciences.

EIKO Lifesciences Stock Index Membership

See which indices include EIKO Lifesciences stock. Check EIKO index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
EIKO Lifesciences is not part of any tracked indices.
Only major market indices are tracked in our system.

EIKO Lifesciences Market Events Screener - Corporate Actions

Get EIKO Lifesciences corporate actions including splits, bonuses, and buybacks. Check EIKO Lifesciences stock events that may affect EIKO share price.
Announcement Date Record Date Event Type Information Price Impact
2026-09-22 2026-09-22 Annual General Meeting NA -2.19%
2026-08-12 2026-08-12 Quarterly Result Announcement NA -0.04%
2026-05-26 2026-05-26 Quarterly Result Announcement NA 0.67%
2026-01-29 2026-01-29 Quarterly Result Announcement NA -6.23%
2026-01-07 2026-01-07 Extraordinary General Meeting NA 0.53%
2025-10-31 2025-10-31 Quarterly Result Announcement NA 1.80%
2025-09-05 2025-09-05 Annual General Meeting NA -0.87%
2025-07-29 2025-07-29 Quarterly Result Announcement NA -4.48%
2025-05-14 2025-05-14 Quarterly Result Announcement NA -0.10%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -15.01%
2024-10-19 2024-10-19 Quarterly Result Announcement NA -6.07%
2024-09-28 2024-09-28 Annual General Meeting NA 0.68%
2023-07-07 2023-07-07 Rights 2:3 10.17%
2021-03-01 2021-03-01 Change Of Name NA 0.00%

EIKO Lifesciences Competitors Screener - Peer Comparison

Screen EIKO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Pidilite Industries 155,944 59.62 14,867 11.05% 2,471 37.47
SRF 73,018 34.05 15,894 7.20% 1,835 31.67
Gujarat Fluorochemicals 50,575 87.36 5,126 5.63% 574 59.29
Navin Fluorine International 42,402 55.50 3,379 41.21% 664 55.29
Himadri Speciality Chemical 32,318 41.71 4,832 3.60% 755 40.23
Deepak Nitrite 21,401 27.63 7,947 -5.01% 551 31.74
Aether Industries 21,165 94.41 1,181 34.17% 220 59.62
Atul 17,918 22.67 6,476 13.77% 689 37.82
Aarti Industries 17,093 33.62 8,291 13.78% 419 41.93
Fine Organic Industries 15,790 36.12 2,483 4.89% 417 52.07

EIKO Lifesciences Company Announcements - News Screener

Screen EIKO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-08-27 Compliance Under Regulation 36 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 (The Listing Regulations) -
2026-08-25 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-24 Reg. 34 (1) Annual Report. -
2026-08-24 49Th Annual General Meeting Of The Company Will Be Held On Tuesday 22Nd Day Of September 2026 At 04:00 P.M. (IST) Through Video Conferencing/ Other Audio Visual Means. -
2026-08-24 Announcement under Regulation 30 (LODR)-Resignation of Director -
2026-08-24 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-24 Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday 24Th August 2026 -
2026-08-18 Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 -
2026-08-18 Announcement under Regulation 30 (LODR)-Allotment -
2026-08-13 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-12 Board Meeting Outcome for Approved Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June 2026 Along With Limited Review Report Issued By The Statutory Auditors Of The Company. -
2026-08-07 Board Meeting Intimation for Meeting Scheduled To Be Held On 12Th August 2026 -
2026-07-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-24 Closure of Trading Window -
2026-05-27 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-26 Announcement under Regulation 30 (LODR)-Change in Management -
2026-05-26 Board Meeting Outcome for Outcome Of The Board Meeting -
2026-05-25 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-21 Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ending On 31St March 2026 In Accordance With Regulation 33 Of The SEBI Listing Regulation. -
2026-04-09 Non Applicability Of Annual Disclosure As Per SEBI Circular - Fund Raising By Issuance Of Debt Securities By Large Corporates. -